Normal and Neoplastic Growth Regulation in the Brain

$1,386,209P01FY2004CANIH

St. Jude Children'S Research Hospital, Memphis TN

Investigators

Linked publications & trials

Paper 39638997 Paper 39589865 Paper 39557842 Paper 39313329 Paper 38885332 Paper 38849845 Paper 38664416 Paper 38466086 Paper 38411252 Paper 38350450 Paper 38266099 Paper 37992682 Paper 37988981 Paper 37971169 Paper 37596258 Paper 37503880 Paper 37488363 Paper 37438132 Paper 37355765 Paper 37333156 Paper 37321859 Paper 37183219 Paper 37119408 Paper 37020038 Paper 36971093 Paper 36918226 Paper 36786675 Paper 36765089 Paper 36732477 Paper 36437415 Paper 36318650 Paper 36260562 Paper 36175668 Paper 36131015 Paper 35914226 Paper 35899386 Paper 35798383 Paper 35709750 Paper 35642016 Paper 35403869 Paper 35102167 Paper 34997202 Paper 34788079 Paper 34723800 Paper 34644147 Paper 34614283 Paper 34524863 Paper 34215733 Paper 34211478 Paper 34042448 Paper 33963961 Paper 33939327 Paper 33749791 Paper 33563660 Paper 33355188 Paper 33320196 Paper 33148882 Paper 32651255 Paper 32553121 Paper 32519082 Paper 32502305 Paper 32466770 Paper 31948942 Paper 31859390 Paper 31822998 Paper 31669383 Paper 31566663 Paper 31511697 Paper 31420543 Paper 31399583 Paper 31316100 Paper 31243155 Paper 31150022 Paper 31079218 Paper 30976974 Paper 30901264 Paper 30885981 Paper 30770999 Paper 30733593 Paper 30726976 Paper 30595505 Paper 30538199 Paper 30420702 Paper 30366006 Paper 30324526 Paper 30267146 Paper 30262806 Paper 30205039 Paper 30019219 Paper 29999454 Paper 29949764 Paper 29909548 Paper 29880921 Paper 29778738 Paper 29774125 Paper 29753700 Paper 29698863 Paper 29514916 Paper 29514827 Paper 29339161

Abstract

The goal of this program project is to increase understanding of the molecular basis of normal and neoplastic growth in the developing brain. The ultimate objective is to use this knowledge to devise novel strategies for treatment of medulloblastoma, the most common pediatric malignancy of the central nervous system. This objective is being pursued through four interactive projects that investigate the role of different signaling pathways in the growth of the central nervous system and brain tumors supported by an Administrative Core and a Bioinformatics and Microarray Core. In Project 1, T. Curran utilizes a mouse model of medulloblastoma to investigate the role of the Shh/Ptc/Smo pathway in tumorigenesis. This involves the use of pharmacological inhibitors in cell culture and in vivo, a molecular characterization of Gill and comparison of the epigenetic and genetic alterations underlying medulloblastoma by nuclear transplant into oocytes. In Project 2, P. McKinnon investigates the contribution of DNA damage signaling to medulloblastoma formation. This project is based on the characterization of a novel model for medulloblastoma in mice lacking DNA Ligase IV and p53. This analysis will involve comparison of gene expression microarray profiles of the different medullobalstomas in the program. In Project 3, R. Gilbertson is investigating the role of ERBB2 in human medulloblastoma. This involves the characterization of human medulloblastoma cell lines using pharmacological and gene expression microarray approaches. The information will be compared to the data obtained on mouse models and an existing database of human brain tumors. A mouse model will be created in which ERBB2 is expressed in cerebellar granule neurons. In Project 4, S. Baker is studying the role of the Pten signaling pathway in growth regulation in the brain. This includes characterization of the function of downstream effector genes in the cerebellum and the creation of new mutant mouse strains to investigate its contribution to growth, proliferation and tumorigenesis.

View original record on NIH RePORTER →